Table 3. Characteristics of NAFLD patients according to microbiota diversity index (OTU, Shannon-Weaver Index, and Simpson’s Diversity Index).
OTU | p value | Shannon-Weaver Index | P value | Simpson Diversity Index | p value | |
---|---|---|---|---|---|---|
Fibrosis | ||||||
Non Significant | 155 (90–331) | 0.141 | 3.94 (1.63–5.43) | 0.245 | 0.88 (0.38–0.95) | 0.473 |
Significant | 190 (101–296) | 4.39 (2.93–5.59) | 0.90 (0.76–0.96) | |||
Steatosis | ||||||
Non Significant | 155 (93–331) | 0.808 | 3.94 (1.63–5.33) | 0.447 | 0.86 (0.38–0.95) | 0.213 |
Significant | 177 (90–269) | 4.22 (2.58–5.59) | 0.90 (0.75–0.96) | |||
BMI | ||||||
Non Obese | 177 (99–331) | 0.527 | 4.45 (1.63–5.43) | 0.183 | 0.91 (0.38–0.95) | 0.080 |
Obese | 176 (90–296) | 3.92 (2.31–5.59) | 0.87 (0.60–0.96) | |||
Central obesity | ||||||
No | 192 (155–214) | 0.404 | 4.54 (4.06–4.98) | 0.221 | 0.91 (0.88–0.94) | 0.266 |
Yes | 176 (90–331) | 4.11 (1.63–6.59) | 0.88 (0.38–0.96) | |||
Triglyceride | ||||||
Normal | 183 (101–331) | 0.010* | 4.33 (3.06–5.59) | 0.005* | 0.91 (0.76–0.96) | 0.003* |
Increase | 118 (90–201) | 3.68 (1.63–4.41) | 0.83 (0.38–0.90) | |||
HDL | ||||||
Normal | 188 (97–296) | 0.158 | 4.38 (1.63–5.59) | 0.064 | 0.91 (0.38–0.96) | 0.114 |
Decrease | 151 (90–331) | 3.84 (2.31–5.33) | 0.87 (0.60–0.94) | |||
LDL | ||||||
Normal | 169 (106–331) | 0.929 | 4.15 (3.06–5.33) | 0.546 | 0.90 (0.80–0.94) | 0.339 |
Increase | 180 (90–296) | 4.14 (1.63–5.59) | 0.88 (0.38–0.96) | |||
Diabetes mellitus | ||||||
No | 181 (112–220) | 0.684 | 4.06 (3.76–4.96) | 0.816 | 0.88 (0.84–0.95) | 0.485 |
Yes | 172 (90–331) | 4.18 (1.63–5.59) | 0.88 (0.38–0.96) |
Data are presented as medians (minimum-maximum). NAFLD: non-alcoholic fatty liver disease; OTU: operational taxonomic unit; BMI: body mass index; HLD: high-density lipoprotein; LDL: low-density lipoprotein. *Statistically significant by Mann-Whitney test.